The cancer Doc, driven by impact

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Showalter, Radiation Oncologist, Founder and Chief Medical Officer at ArteraAI.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tim, covering:

• The attraction of radiation oncology at med school and his fascination with clinical trials
• His frustration with tools for cervical cancer patients led to the creation of a medical device company
• How his bootstrapped side project ended in an exit... but why that was inspiring and motivational to move on to the next thing
• The proud experience of using his own product (BrachyGel) on cancer patients in the clinic, years after coming up with the idea
• How ArteraAI's technology is positively disrupting the prostate cancer space, as well as its potential to scale and expand into other disease areas

 

Tim Showalter, MD, MPH, is a radiation oncologist and cancer researcher who serves as Chief Medical Officer at Artera, where he leads research and medical strategy. Artera is working to improve cancer care by developing AI-enabled prognostic and predictive tests. The ArteraAI Prostate Test is the first of its kind to be recommended by national clinical guidelines for routine use. Tim maintains a part-time clinical practice at the University of Virginia, remaining connected to patient care, research and education.

He is the founder of Advaray and inventor of BrachyGel, a novel hydrogel-based medical device for cervical cancer radiation therapy, which is manufactured and marketed by CQ Medical. Tim serves on the board of CQ Medical and cohosts a podcast, HealthTech Remedy to explore the intricacies of innovative health technology companies. Tim is a noted speaker and advisor to start-up companies.

 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! 

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.